ACADIA Pharmaceuticals Inc. (ACAD)

ACADIA Pharmaceuticals Revenue

ACADIA Pharmaceuticals had revenue of $205.83M in the quarter ending March 31, 2024, with 73.75% growth. This brings the company's revenue in the last twelve months to $813.81M, up 56.43% year-over-year. In the year 2023, ACADIA Pharmaceuticals had annual revenue of $726.44M with 40.45% growth.

• Revenue (ttm): $813.81M
• Revenue Growth: +56.43%
• P/S Ratio: 3.89
• Revenue / Employee: $1,360,880
• Employees: 598
• Market Cap: 3.16B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	726.44M	209.20M	40.45%
Dec 31, 2022	517.24M	33.09M	6.83%
Dec 31, 2021	484.15M	42.39M	9.60%
Dec 31, 2020	441.76M	102.68M	30.28%
Dec 31, 2019	339.08M	115.27M	51.50%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.